(Q46677272)

24 December 2017

title

A randomized trial of iloprost in patients with intermittent claudication (English)

1 reference

24 December 2017

main subject

randomized experiment

1 reference

1 reference

3

William R Hiatt

1 reference

24 December 2017

author name string

Mark A Creager

series ordinal

1

1 reference

24 December 2017

Reena L Pande

series ordinal

2

1 reference

24 December 2017

publication date

1 February 2008

1 reference

24 December 2017

published in

Vascular Medicine

1 reference

24 December 2017

volume

13

1 reference

24 December 2017

issue

1

1 reference

24 December 2017

page(s)

5-13

1 reference

24 December 2017

Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Update on Some Epidemiologic Features of Intermittent Claudication: The Framingham Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Medical treatment of peripheral arterial disease and claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Meta-analysis of results from eight randomized, placebo-controlled trials on the effect of cilostazol on patients with intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Iloprost. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peripheral vascular disease, myocardial ischaemia and extracorporeal circulation procedures

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Prostanoid drug therapy for peripheral arterial occlusive disease--the European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Beneficial effect of a new prostacyclin derivative on the walking capacity in patients with peripheral arterial insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

The effects of prostaglandin E-1 in patients with intermittent claudication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

PGE1 and other prostaglandins in the treatment of intermittent claudication: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Studies on the effectiveness and safety of cilostazol, beraprost sodium, prostaglandin E1 for the treatment of intermittent claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Prostanoids in the treatment of intermittent claudication--a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Treatment of intermittent claudication with beraprost sodium, an orally active prostaglandin I2 analogue: a double-blinded, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

Failure of pentoxifylline or cilostazol to improve blood and plasma viscosity, fibrinogen, and erythrocyte deformability in claudication

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1358863X07084910

21 January 2018

Identifiers

DOI

10.1177/1358863X07084910

1 reference

24 December 2017

1 reference

24 December 2017